Additional pathways included regulation of eNOS pathway enriched for breast cancer, transcriptional role of AP1 for endometrial cancer, activin A signal regulation, and development of beta-adrenergic receptor transactivation of EGFR enriched for ovarian cancer. Here, EGFR is linked to ovarian cancer.